The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis.
Document type:
Journal Article
Author(s):
Kremer, M; Horn, T; Dechow, T; Tzankov, A; Quintanilla-Martinez, L; Fend, F